The Green Bay Packers, Bellin Overall health, and the Vince Lombardi Cancer Foundation have partnered for the seventh consecutive year to launch the Packers Vs. Cancer campaign. This initiative aims to raise awareness about all varieties of cancers, produce funds for study and care, and emphasize the significance of early screenings in saving lives.
Packers President/CEO Mark Murphy expressed his pleasure in continuing the Packers Vs. Cancer work and displaying help for cancer individuals and their loved ones. He acknowledged the important effect the campaign has had in the previous six years and highlighted the collaboration with Bellin Overall health and the Vince Lombardi Cancer Foundation. The Packers organization is committed to contributing to cancer study funding and reminding fans to prioritize screenings.
To kick off the campaign, Packers cornerback Keisean Nixon and operating back Patrick Taylor joined representatives from Bellin Overall health and the Vince Lombardi Cancer Foundation at the Bellin Overall health Cancer Group. Nixon, this year’s campaign spokesperson, shared his family’s knowledge with cancer, adding a individual touch to the announcement.
Subsequently, the group received a tour of the Bellin Overall health Cancer Group facility, which delivers a variety of cancer remedy and help solutions such as health-related and radiation oncology, infusion solutions, oncology genetics, and physical and speech therapy. Bellin Overall health annually administers about 15,000 infusions and ten,000 total radiation therapies.
As portion of this year’s Packers Vs. Cancer campaign, a new Packers Vs. Cancer hat has been introduced. Every single sale of this hat will contribute $five straight to the Vince Lombardi Cancer Foundation. The hat, a green New Era winter knit with the Packers logo on the front and the Packers Vs. Cancer logo on the side, is presently offered for buy each in-retailer and on the web. Furthermore, shoppers at the Packers Pro Shop have the chance to donate $1 or additional to the Vince Lombardi Cancer Foundation for the duration of their buy till October 16, creating help for ongoing cancer study applications.
